[Assessment of antihypertensive efficacy of moexipril in metabolic syndrome].
Ivleva
A Ia
AIa
Moskvicheva
Iu B
IuB
Poluianova
N V
NV
Minina
E S
ES
Kolesnikova
A V
AV
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001795:Blood Pressure Determination; D015992:Body Mass Index; D002784:Cholesterol / Q000097:blood; D003627:Data Interpretation, Statistical; D005260:Female; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D008875:Middle Aged; D012307:Risk Factors; D019722:Sphygmomanometers; D044005:Tetrahydroisoquinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D044005:Tetrahydroisoquinolines; D002784:Cholesterol; C058302:moexipril